Leadership Board of Directors Advisors Our Team About Us Arcturus Therapeutics a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Our team has extensive experience in the discovery and development of mRNA medicines, as well as design and utilization of lipid-mediated drug delivery systems. This combination of in-house expertise, innovative spirit, and passion for what we do, uniquely position us to catalyze the next generation of mRNA medicines. News & Events October 25, 2021 Arcturus Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on November 8, 2021 READ MORE November 8, 2021 Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress READ MORE November 18, 2021 Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) READ MORE November 22, 2021 Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference READ MORE March 4, 2013 Arcturus Therapeutics Begins Operations in Janssen Labs Home Contact Careers Terms and Conditions Privacy Policy © 2021 Arcturus Therapeutics, Inc.